In addition, individuals recovered from critical COVID-19 had elevated levels of activated (defined as CD38+HLA-DR+) CD8+ effector and terminal memory T cells (Bonferroni-adjusted P-value range 5.46 × 10−4–1.04 × 10−6) (Fig. 3e). This evidence concerns the gene CD8A and COVID-19.